Pharmaceutical Marketing - Time for Change

Electronic Journal of Business Ethics and Organization Studies 9 (2):4-11 (2004)
  Copy   BIBTEX

Abstract

This paper reviews current marketing practices in the pharmaceutical sector, and their impact on consumer and doctor behaviour. It identifies negative impacts which include misleading advertising, disease mongering and escalating costs. It argues the need to move from industry self-regulation to an independently monitored code of practice for pharmaceutical marketing

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Show Me the Evidence: The Ethical Aspects of Pharmaceutical Marketing, Evidence-Based Medicine, and Rational Prescribing.David Pollack, Rick Wopat, John Muench & Daniel Hartung - 2009 - Journal of Ethics in Mental Health 4:1-9.
Brightening Up: The Effect of the Physician Payment Sunshine Act on Existing Regulation of Pharmaceutical Marketing.Igor Gorlach & Genevieve Pham-Kanter - 2013 - Journal of Law, Medicine and Ethics 41 (1):315-322.
From evidence-based medicine to marketing-based medicine: Evidence from internal industry documents. [REVIEW]Glen I. Spielmans & Peter I. Parry - 2010 - Journal of Bioethical Inquiry 7 (1):13-29.
Public Perceptions of Health Care Professionals' Participation in Pharmaceutical Marketing.Nancy J. Crigger, Laura Courter, Kristen Hayes & K. Shepherd - 2009 - Nursing Ethics 16 (5):647-658.
Exposing Nursing Students To the Marketing Methods of Pharmaceutical Companies.Murat Civaner, Ozlem Sarikaya, Sevim Ulupinar Alici & Gulcin Bozkurt - 2008 - Nursing Ethics 15 (3):396-410.
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won’t Cast Light on.Sergio Sismondo - 2013 - Journal of Law, Medicine and Ethics 41 (3):635-643.
Internet Marketing of Neuroproducts: New Practices and Healthcare Policy Challenges.Eric Racine, Hz Adriaan van Der Loos & Judy Illes - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (2):181-194.
The Pharmaceutical Industry and the Construction of Psychiatric Diagnoses.Joanna Moncrieff - 2009 - Journal of Ethics in Mental Health 4:1-4.
The constant gardener revisited: The effect ofsocial blackmail on the marketing concept,innovation, and entrepreneurship. [REVIEW]Morgan P. Miles, Linda S. Munilla & Jeffrey G. Covin - 2002 - Journal of Business Ethics 41 (3):287 - 295.
Understanding physician-pharmaceutical industry interactions.Shaili Jain - 2007 - New York: Cambridge University Press.
Pharmaceutical Medicine.D. M. Burley, Joan M. Clarke & Louis Lasagna - 1993
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Ethically Questionable Behavior in Sales Representatives – An Example from the Taiwanese Pharmaceutical Industry.Ya-Hui Hsu, Wenchang Fang & Yuanchung Lee - 2008 - Journal of Business Ethics 88 (S1):155 - 166.
Distorted Packaging: Marketing Depression as Illness, Drugs as Cure.Paula Gardner - 2003 - Journal of Medical Humanities 24 (1/2):105-130.
Dangerous Medicine: The Pharmaceutical Industry's Questionable Ethical Practices.John T. Fielding - unknown

Analytics

Added to PP
2015-02-05

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

No references found.

Add more references